Novel agents may be preferable to chemotherapy for large B-cell lymphoma progressing after CD19-CAR-T: A multicenter observational study Meeting Abstract

  

Authors:	Tomas, A. A.; Fein, J. A.; Fried, S.; Fingrut, W.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; Lin, R. J.; Scordo, M.; Afuye, A. O.; Batlevi, C. L.; Besser, M.; Dahi, P. B.; Danylesko, I.; Giralt, S.; Imber, B. S.; Jacobi, E.; Nagler, A.; Palomba, M. L.; Salles, G.; Sauter, C. S.; Shah, G. L.; Shem-Tov, N.; Shimoni, A.; Yahalom, J.; Yerushalmi, R.; Avigdor, A.; Perales, M. A.; Shouval, R.
Abstract Title:	Novel agents may be preferable to chemotherapy for large B-cell lymphoma progressing after CD19-CAR-T: A multicenter observational study
Meeting Title:	63rd Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	138
Issue:	Suppl. 1
Meeting Dates:	2021 Dec 11-14
Meeting Location:	Atlanta, GA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2021-11-23
Language:	English
ACCESSION:	WOS:000736398803181
DOI:	10.1182/blood-2021-147568
PROVIDER:	wos
Notes:	Meeting Abstract: 883 -- Hybrid meeting, also took place online -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/198951